Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1957 1
1960 3
1961 2
1963 1
1965 2
1966 1
1967 2
1968 4
1969 1
1970 6
1971 2
1972 6
1973 3
1974 1
1975 1
1976 1
1977 3
1978 2
1980 4
1981 7
1982 7
1983 6
1984 5
1985 2
1986 6
1987 8
1988 7
1989 19
1990 9
1991 8
1992 11
1993 11
1994 12
1995 16
1996 22
1997 29
1998 23
1999 33
2000 26
2001 26
2002 34
2003 43
2004 42
2005 40
2006 47
2007 56
2008 60
2009 88
2010 63
2011 90
2012 87
2013 88
2014 106
2015 112
2016 91
2017 100
2018 108
2019 112
2020 145
2021 165
2022 195
2023 189
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

2,176 results

Results by year

Filters applied: . Clear all
Page 1
Vitamin D in the Prevention and Treatment of Diabetic Neuropathy.
Putz Z, Tordai D, Hajdú N, Vági OE, Kempler M, Békeffy M, Körei AE, Istenes I, Horváth V, Stoian AP, Rizzo M, Papanas N, Kempler P. Putz Z, et al. Among authors: rizzo m. Clin Ther. 2022 May;44(5):813-823. doi: 10.1016/j.clinthera.2022.03.012. Epub 2022 Apr 12. Clin Ther. 2022. PMID: 35428527 Free article. Review.
Obesity and HFpEF.
Clemenza F, Citarrella R, Patti A, Rizzo M. Clemenza F, et al. Among authors: rizzo m. J Clin Med. 2022 Jul 3;11(13):3858. doi: 10.3390/jcm11133858. J Clin Med. 2022. PMID: 35807143 Free PMC article.
Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence.
Muzurović EM, Volčanšek Š, Tomšić KZ, Janež A, Mikhailidis DP, Rizzo M, Mantzoros CS. Muzurović EM, et al. Among authors: rizzo m. J Cardiovasc Pharmacol Ther. 2022 Jan-Dec;27:10742484221146371. doi: 10.1177/10742484221146371. J Cardiovasc Pharmacol Ther. 2022. PMID: 36546652 Free article. Review.
2,176 results